78. 下垂体前葉機能低下症
[臨床試験数:462,薬物数:346(DrugBank:45),標的遺伝子数:41,標的パスウェイ数:80

Searched query = "Hypopituitarism", "Anterior pituitary hypothyroidism", "Syndrome of abnormal secretion of gonadotropin", "Hyposecretion of gonadotropins", "Adrenocorticotropic hormone deficiency", "ACTH deficiency", "Thyroid-stimulating hormone deficiency", "TSH deficiency", "Growth hormone deficiency", "GH deficiency", "GHD", "CGHD", "AGHD", "Prolactin deficiency", "PRL deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
8 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03290235
(ClinicalTrials.gov)
March 1, 201719/9/2017Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in ChildrenThe Extension Study of Phase IV Clinical Trial of Pegylated Somatropin (PEG Somatropin) to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in ChildrenGrowth RetardationDrug: PEG-somatropinGeneScience Pharmaceuticals Co., Ltd.NULLRecruiting42 Months15 YearsAll1500Phase 4China
2NCT02976675
(ClinicalTrials.gov)
January 201524/11/2016Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone DeficiencyPegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency: A Multicenter, Randomized, Open-label, Parallel Phase IV Clinical Trial With Different Administration Frequency of PEG SomatropinGrowth Hormone DeficiencyBiological: PEG-somatropinGeneScience Pharmaceuticals Co., Ltd.Children's Hospital of Fudan University;Suzhou Municipal Hospital;General Hospital of Ningxia Medical University;The First Affiliated Hospital of Henan University of Science and Technology;Maternal and Child Health Hospital of Hubei Province;Nantong UniversityRecruiting3 Years18 YearsAll600Phase 4China
3NCT03249480
(ClinicalTrials.gov)
January 201524/7/2017Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone DeficiencyPegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency: A Multicenter, Open-label, Phase IV Clinical Trial With Different Administration Dosage of PEG SomatropinGrowth Hormone DeficiencyBiological: PEG-somatropinGeneScience Pharmaceuticals Co., Ltd.Beijing Children's Hospital;Tianjin Medical University General Hospital;Peking University Third Hospital;China-Japan Friendship Hospital;Dalian Children's Hospital;Xi'an Children's Hospital;Wuhan Children's Hospital;Fuzhou Children s Hospital;Anhui Provincial Children's Hospital;Hunan Children's Hospital;Shenzhen Children's Hospital;Children's Hospital of Hebei Province;Second Affiliated Hospital of Xi'an Jiaotong University;Children's Hospital of Zhengzhou;Children's Hospital Of Soochow University;Maternal & Child Health Hospital of Guangxi Zhuang Autonomous Region;The First Affiliated Hospital of Kunming Medical College;Kunming Children's Hospital;The First People's Hospital of Yunnan;Xuzhou Children's Hopspital;Henan Provincal People's Hospital;The First Affiliated Hospital of Henan University of Traditional Chinese Medicine;First Affiliated Hospital of Harbin Medical University;The Second Hospital of Hebei Medical University;Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University;Union Hospital of Tongji Medical College of HUST;Wuxi Children's Hospital;The Second Affiliated Hospital of Kunming Medical University;Nanjing Children's HospitalRecruiting3 Years18 YearsAll900Phase 4China
4NCT02380235
(ClinicalTrials.gov)
December 20142/3/2015Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)Growth Hormone DeficiencyBiological: PEG-somatropinGeneScience Pharmaceuticals Co., Ltd.NULLRecruiting3 Years18 YearsAll600Phase 4China
5NCT02908958
(ClinicalTrials.gov)
November 201419/9/2016Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone DeficiencyClinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Children Growth Hormone Deficiency: A Multicenter, Randomized, Parallel, Dose-control Clinical Trial IIGrowth Hormone DeficiencyBiological: PEG-somatropinGeneScience Pharmaceuticals Co., Ltd.The Children's Hospital of Zhejiang University School of Medicine;The Second Hospital of Anhui Medical University;Guangzhou Women and Children's Medical Center;First People's Hospital of Hangzhou;Qilu Hospital of Shandong University;Zhejiang Provincial People’s Hospital;Zhejiang Provincial Hospital of TCM;Central South University;Southwest Hospital, China;First Affiliated Hospital of Guangxi Medical University;Shanghai Children's Medical Center;Second Affiliated Hospital of Wenzhou Medical University;The First Affiliated Hospital of Xiamen University;Third Affiliated Hospital, Sun Yat-Sen University;Xiangya Hospital of Central South University;Shaoxing Second HospitalRecruiting3 Years18 YearsAll900Phase 4China
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT02314676
(ClinicalTrials.gov)
November 201427/11/2014Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency ChildrenDwarfism, PituitaryBiological: PEG-somatropinGeneScience Pharmaceuticals Co., Ltd.NULLRecruiting3 YearsN/ABoth900Phase 4China
7NCT01495468
(ClinicalTrials.gov)
March 200716/12/2011Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency ChildrenPegylated Somatropin in the Treatment of Children With Growth Hormone Deficient:A Multicenter, Randomized, Open-label, Controlled Phase ? Clinical TrialGrowth Hormone DeficiencyBiological: PEG-somatropinGeneScience Pharmaceuticals Co., Ltd.Tongji Hospital;First Affiliated Hospital, Sun Yat-Sen University;Capital Medical University;Children's Hospital of Fudan University;First Hospital of Jilin UniversityCompleted8 Years15 YearsAll343Phase 3China
8NCT01342146
(ClinicalTrials.gov)
May 200621/4/2011Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency ChildrenEfficiency and Safety of Pegylated Somatropin(PEG-somatropin) in the Treatment of Children With Growth Hormone Deficiency: a Multicenter, Randomized, Open-label, Controlled Phase 2 StudyGrowth Hormone DeficiencyDrug: pegylated Somatropin;Drug: Jintropin AQGeneScience Pharmaceuticals Co., Ltd.Huazhong University of Science and Technology;First Affiliated Hospital, Sun Yat-Sen University;Capital Medical University;Children's Hospital of Fudan UniversityCompletedN/AN/AAll101Phase 2NULL